Private Equity
Private Equity
All Portfolio items
See full Private Equity portfolio
KLIFO is a leading drug development consultancy with significant experience in partnering with biotech and pharmaceutical companies to advance their drug development projects. KLIFO offers multi-disciplinary consulting and operational solutions spanning all areas of clinical research, clinical trial supply, CMC development, regulatory affairs, pharmacovigilance, and the development of pharmaceutical and biotech products and medical devices. The company is a leader in the Scandinavian market and has fast growing operations in Germany and the Netherlands. The company aims to grow and deepen it offering and geographic presence organically and through an active buy and build strategy.
More Klifo news
Chr. Diener / Koscher & Würtz
With the acquisition of Chr. Diener in 2022 and Koscher & Würtz (K&W) in 2023,...
NIZO
NIZO is a state-of-the art, globally operating contract research organization for better food and health,....
Detax
DETAX is a leading global supplier of biocompatible silicones and light-curing 3D resins for medical...